Association between C-reactive protein and chronic pain in US adults: A nationwide cross-sectional study.

Chunsheng Huang, Qizhen Tong, Qiaoling Tong
Author Information
  1. Chunsheng Huang: Department of Anesthesiology, Ningbo Medical Center Lihuili Hospital, Medical School of Ningbo University, Ningbo, Zhejiang, China.
  2. Qizhen Tong: Department of Operating Room, Ningbo Yinzhou District Integrated Hospital of Traditional Chinese and Western Medicine, Ningbo, China.
  3. Qiaoling Tong: Department of Otolaryngology, Ningbo NO.2 Hospital, Ningbo, Zhejiang, China. ORCID

Abstract

BACKGROUND: Chronic pain has emerged as a significant global public health concern. Hence, it is imperative to acquire a more comprehensive comprehension of these characteristics in the adult population of the United States in order to facilitate the development of effective interventions. The objective of this study is to ascertain the prevalence of chronic pain among people in the United States and investigate its association with C-reactive protein (CRP) levels.
METHODS: The present study employed a cross-sectional design and utilized data from three cycles of the National Health and Nutrition Examination Survey (NHANES). The study aimed to investigate the relationship between chronic pain status, CRP levels, and potential confounding factors. The study incorporated individuals who successfully fulfilled chronic questionnaires and had CRP assays. Weighted univariate and multivariate logistic regression analyses were performed to examine the correlation between chronic pain and CRP levels. To explore the non-linear relationship, weighted restricted cubic spline (RCS) with three knots coupled with a weighted logistic regression model to assess the dose-response relationship between CRP (continuous variables) and chronic pain.
RESULTS: A total of 10,680 (Weighted 250,814,660.8) adult participants with complete information were included in the analysis and 2612 (Weighted 67978784.88, 27.1%) subjects met the definition of chronic pain. Compared with participants without chronic pain, those with chronic pain had a higher CRP level (P���< 0.001). The results of the multivariable adjusted logistic regression model suggested that the highest CRP quartile (CRP >��� 0.52���mg/dL) was associated with a 32% increase in the risk of chronic pain compared with the lowest CRP quartile (CRP ������ 0.09���mg/dL). The RCS result showed that the OR of chronic pain and CRP displayed a linear relationship (P =���0.027, Non-linear P =���0.541).
CONCLUSIONS: The study found a significant correlation between CRP levels and the presence of chronic pain among people in the United States. Individuals exhibiting elevated levels of CRP demonstrated a heightened propensity for experiencing chronic pain in comparison to individuals with lower CRP levels. Additional investigation is necessary to explore the presence of a causal association between the two variables, as well as the potential underlying mechanisms.

References

  1. Nat Rev Neurol. 2023 Apr;19(4):199-220 [PMID: 36859719]
  2. Pain. 2019 Jan;160(1):53-59 [PMID: 30586071]
  3. Semin Arthritis Rheum. 2021 Feb;51(1):219-229 [PMID: 33385862]
  4. Subst Abuse Treat Prev Policy. 2017 Aug 15;12(1):36 [PMID: 28810899]
  5. Front Immunol. 2023 Jan 13;13:1087648 [PMID: 36713369]
  6. Pain. 2023 Mar 1;164(3):638-644 [PMID: 35972466]
  7. Arthritis Care Res (Hoboken). 2011 Mar;63(3):320-7 [PMID: 20957660]
  8. Lancet. 2021 May 29;397(10289):2098-2110 [PMID: 34062144]
  9. Br J Anaesth. 2022 Sep;129(3):355-365 [PMID: 35410791]
  10. Pharmacol Rep. 2020 Feb;72(1):104-114 [PMID: 32016833]
  11. Brain Behav Immun. 2017 Feb;60:84-92 [PMID: 27720935]
  12. Br J Anaesth. 2019 Nov;123(5):637-654 [PMID: 31551115]
  13. Pain Res Manag. 2018 Feb 7;2018:8564215 [PMID: 29623147]
  14. Intensive Care Med. 2022 Jan;48(1):103-105 [PMID: 34825257]
  15. BMJ. 2015 Jul 29;351:h2730 [PMID: 26224572]
  16. J Gerontol Nurs. 2021 Jul;47(7):6-15 [PMID: 34191653]
  17. Cell Rep. 2022 Dec 13;41(11):111833 [PMID: 36516746]
  18. Adv Nutr. 2016 Jan 15;7(1):121-34 [PMID: 26773020]
  19. Pharmacotherapy. 2018 Mar;38(3):382-389 [PMID: 29377216]
  20. Sci Transl Med. 2022 May 11;14(644):eabj9954 [PMID: 35544595]
  21. Pain. 2019 Jan;160(1):19-27 [PMID: 30586067]
  22. Brain Behav Immun. 2015 May;46:33-4 [PMID: 25596175]
  23. J Pain. 2016 Sep;17(9 Suppl):T10-20 [PMID: 27586827]
  24. Br J Anaesth. 2019 Aug;123(2):e273-e283 [PMID: 31079836]
  25. JAMA Intern Med. 2020 Jan 1;180(1):91-105 [PMID: 31682676]
  26. Pain. 2018 Mar;159(3):595-602 [PMID: 29447138]
  27. Int J Mol Sci. 2023 May 23;24(11): [PMID: 37298077]
  28. J Clin Endocrinol Metab. 2022 May 17;107(6):e2523-e2531 [PMID: 35137178]
  29. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:284-290 [PMID: 31004724]
  30. Phys Ther. 2018 May 1;98(5):325-335 [PMID: 29425327]
  31. MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006 [PMID: 30212442]
  32. Neuropsychopharmacology. 2021 May;46(6):1071-1077 [PMID: 32179874]
  33. Science. 2016 Nov 4;354(6312):572-577 [PMID: 27811267]
  34. Lancet. 2021 May 29;397(10289):2082-2097 [PMID: 34062143]

MeSH Term

Humans
C-Reactive Protein
Chronic Pain
Male
Female
Cross-Sectional Studies
United States
Adult
Middle Aged
Nutrition Surveys
Aged
Prevalence
Young Adult

Chemicals

C-Reactive Protein

Word Cloud

Created with Highcharts 10.0.0CRPpainchronicstudylevelsrelationshipUnitedStatesWeightedlogisticregression0significantadultamongpeopleinvestigateassociationC-reactiveproteincross-sectionalthreepotentialindividualscorrelationexploreweightedRCSmodelvariablesparticipantsquartileP=���0presenceBACKGROUND:ChronicemergedglobalpublichealthconcernHenceimperativeacquirecomprehensivecomprehensioncharacteristicspopulationorderfacilitatedevelopmenteffectiveinterventionsobjectiveascertainprevalenceMETHODS:presentemployeddesignutilizeddatacyclesNationalHealthNutritionExaminationSurveyNHANESaimedstatusconfoundingfactorsincorporatedsuccessfullyfulfilledquestionnairesassaysunivariatemultivariateanalysesperformedexaminenon-linearrestrictedcubicsplineknotscoupledassessdose-responsecontinuousRESULTS:total106802508146608completeinformationincludedanalysis26126797878488271%subjectsmetdefinitionComparedwithouthigherlevelP���<001resultsmultivariableadjustedsuggestedhighest>���52���mg/dLassociated32%increaseriskcomparedlowest������09���mg/dLresultshowedORdisplayedlinear027Non-linear541CONCLUSIONS:foundIndividualsexhibitingelevateddemonstratedheightenedpropensityexperiencingcomparisonlowerAdditionalinvestigationnecessarycausaltwowellunderlyingmechanismsAssociationUSadults:nationwide

Similar Articles

Cited By

No available data.